Insider Trading Activity CytomX Therapeutics Inc (NASDAQ:CTMX) – Insider Sold 23,840 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For CytomX Therapeutics Inc (NASDAQ:CTMX)

Rachel Humphrey , Insider of CytomX Therapeutics Inc (NASDAQ:CTMX) reportedly Sold 23,840 shares of the company’s stock at an average price of 30 for a total transaction amount of $715,200.00 SEC Form

Insider Trading History For CytomX Therapeutics Inc (NASDAQ:CTMX)

On 10/14/2015 James E Flynn, Insider, bought 625,000 with an average share price of $12.00 per share and the total transaction amounting to $7,500,000.00.

On 10/14/2015 Frederick W Gluck, Director, bought 15,000 with an average share price of $12.00 per share and the total transaction amounting to $180,000.00.

On 10/14/2015 Cynthia J Ladd, VP, bought 3,000 with an average share price of $12.00 per share and the total transaction amounting to $36,000.00.

On 5/20/2016 Ix L.P. Canaan, Director, sold 8,687 with an average share price of $10.10 per share and the total transaction amounting to $87,738.70.

On 5/24/2016 Ix L.P. Canaan, Director, sold 13,253 with an average share price of $10.09 per share and the total transaction amounting to $133,722.77.

On 5/26/2016 Timothy M Shannon, Director, sold 51,343 with an average share price of $10.34 per share and the total transaction amounting to $530,886.62.

On 5/27/2016 Ix L.P. Canaan, Director, sold 25,082 with an average share price of $10.60 per share and the total transaction amounting to $265,869.20.

Analyst Ratings History For CytomX Therapeutics Inc (NASDAQ:CTMX)

On 3/20/2017 Instinet Boost Price Target of rating Sell with a price target of $21.00 to $32.00
On 5/8/2017 HC Wainwright Reiterated Rating Buy
On 8/8/2017 Cann Reiterated Rating Hold
On 8/25/2017 Jefferies Group Set Price Target of rating Buy with a price target of $25.00
On 10/4/2017 Wedbush Set Price Target of rating Buy with a price target of $26.00 to $37.00
On 10/4/2017 Nomura Boost Price Target of rating Buy with a price target of $44.00
On 10/4/2017 Bank of America Boost Price Target of rating Buy with a price target of $30.00 to $34.00

Recent Trading Activity for CytomX Therapeutics Inc (NASDAQ:CTMX)
Shares of CytomX Therapeutics Inc closed the previous trading session at 30.87 up +1.11 3.73% with 29.68000030517578 shares trading hands.